Oxolife is a small-sized clinical-stage company focused on the development of products in female fertility therapeutic area. Current pipeline includes a "first-in-class" pharmacological product, OXO-001, for the embryo implantation increase in woman under assisted reproductive technologies and ovulation recovery in polycystic ovarian syndrome patients.

Main sector: Medic biotechnology